Molecular mechanisms underlying the beneficial effects of Urocortin 2 in pulmonary arterial hypertension

被引：0
|
作者：
Maia-Rocha, C. [1 ]
Adao, R. [1 ]
Mendes-Ferreira, P. [1 ]
Santos-Ribeiro, D. [1 ]
Rademaker, M. [2 ]
Leite-Moreira, A. F. [1 ]
Bras-Silva, C. [1 ]
机构：
[1] Univ Porto, Dept Physiol & Cardiothorac Surg, Fac Med, Oporto, Portugal
[2] Univ Otago Christchurch, Christchurch Heart Inst, Dept Med, Christchurch, New Zealand
来源：
CARDIOVASCULAR RESEARCH | 2016年 / 111卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
424
引用
收藏
页码：S75 / S76
页数：2
相关论文
共 50 条
  • [21] Validating the Zebrafish Aortic Arch Development as a Model to Study the Molecular Mechanisms Underlying Idiopathic Pulmonary Arterial Hypertension
    Carr, P. L.
    Jiang, Z.
    Savage, A. M.
    Noel, E. S.
    Wilkinson, R. N.
    Lawrie, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [22] Beneficial Effects of Inspiratory Muscle Training in Patients With Pulmonary Arterial Hypertension
    Alpert, Martin A.
    AMERICAN JOURNAL OF CARDIOLOGY, 2023, 203 : 526 - 527
  • [23] Cellular Mechanisms Underlying the Pathogenetic Role of the Primary Cilium in Pulmonary Arterial Hypertension
    Melnikov, A.
    Solymosi, P. D.
    Pennitz, P.
    Schupp, J. C.
    Nouailles, G.
    Perret, P.
    Gallo, K.
    Hegemann, N.
    Veetil, N. Nambiar
    Klepetko, W.
    Sinn, K.
    Erfinanda, L.
    Simmons, S.
    Kucherenko, M. M.
    Knosalla, C.
    Preissner, R.
    Kwapiszewska, G.
    Witzenrath, M.
    Kuebler, W. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [24] Molecular mechanisms for disease progression in pulmonary arterial hypertension.
    James, V
    Aldred, MA
    Flanagan, JA
    Southwood, M
    Atkinson, C
    Morrell, NW
    Trembath, RC
    JOURNAL OF MEDICAL GENETICS, 2004, 41 : S81 - S81
  • [25] Urocortin-2 improves right ventricular function and attenuates pulmonary arterial hypertension
    Adao, Rui
    Mendes-Ferreira, Pedro
    Santos-Ribeiro, Diana
    Maia-Rocha, Carolina
    Pimentel, Luis D.
    Monteiro-Pinto, Claudia
    Mulvaney, Eamon P.
    Reid, Helen M.
    Kinsella, B. Therese
    Potus, Francois
    Breuils-Bonnet, Sandra
    Rademaker, Miriam T.
    Provencher, Steeve
    Bonnet, Sebastien
    Leite-Moreira, Adelino F.
    Bras-Silva, Carmen
    CARDIOVASCULAR RESEARCH, 2018, 114 (08) : 1165 - 1177
  • [26] Urocortin-2 treatment reduces right ventricular dysfunction in pulmonary arterial hypertension
    Adao, R.
    Mendes-Ferreira, P.
    Maia-Rocha, C.
    Santos-Ribeiro, D.
    Potus, F.
    Breuils-Bonnet, S.
    Provencher, S.
    Bonnet, S.
    Rademaker, M. T.
    Leite-Moreira, A. F.
    Bras-Silva, C.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1103 - 1103
  • [27] Bioinformatic exploration of the immune related molecular mechanism underlying pulmonary arterial hypertension
    Huang, Ruina
    Zheng, Xifeng
    Wang, Junxian
    BIOENGINEERED, 2021, 12 (01) : 3137 - 3147
  • [28] New Insights into the Mechanisms Underlying Vascular and Cardiac Effects of Urocortin
    Diaz, Ignacio
    Smani, Tarik
    CURRENT VASCULAR PHARMACOLOGY, 2013, 11 (04) : 457 - 464
  • [29] The effects and mechanisms of mycophenolate mofetil on pulmonary arterial hypertension in rats
    Zheng, Yi
    Li, Mingwei
    Zhang, Yongfeng
    Shi, Xuhua
    Li, Luling
    Jin, Mulan
    RHEUMATOLOGY INTERNATIONAL, 2010, 30 (03) : 341 - 348
  • [30] The effects and mechanisms of mycophenolate mofetil on pulmonary arterial hypertension in rats
    Yi Zheng
    Mingwei Li
    Yongfeng Zhang
    Xuhua Shi
    Luling Li
    Mulan Jin
    Rheumatology International, 2010, 30 : 341 - 348
12345